February 22, 2023 02:37 PM EST
Pharma
Marketing

Boehringer In­gel­heim broad­casts third pod­cast sea­son around rare lung con­di­tion

Beth Snyder Bulik

Senior Editor

Boehringer In­gel­heim is back on the pod­cast au­dio waves with the next sea­son of its pul­monary fi­bro­sis se­ries.

In its third sea­son, Boehringer is part­ner­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times